The 2017 BIO World Congress Comes to a Close in Montreal

Jul 26 2017
The 14th annual BIO World Congress drew 954 attendees. The world’s largest industrial biotechnology event hosted more than 227 speakers in seven education tracks and five plenaries and set a new conference record for partnering meetings.

Democrats' Plan on Drug Costs a “Bad Deal for Patients and the Future of American Innovation”

Jul 24 2017
Plan will restrict seniors’ access to prescription drugs and undermine quest for biopharmaceutical innovations and cures Washington, DC (July 24, 2017) – Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement regarding the drug cost plan released today by Congressional Democrats:

Gord Surgeoner to Receive 2017 BIO Leadership and Legacy Award

Jul 18 2017
Dr. Gord Surgeoner, OOnt, former president of Ontario Agri-Food Technologies (OAFT), will receive the 2nd annual BIO Leadership and Legacy Award on Wednesday July 26, 2017, during a lunch plenary session of the 2017 BIO World Congress on Industrial Biotechnology.

BIO Statement on the Status of the U.S.-China 100-Day Plan

Jul 17 2017
Washington, D.C. (July 17, 2017) – The Biotechnology Innovation Organization (BIO) today issued the following statement on the status of the U.S.-China 100-day plan:

Rhode Island Governor Gina Raimondo Presented 2017 BIO Governor of the Year Award

Jul 14 2017
BIO today presented Rhode Island Governor Gina Raimondo with its 2017 Governor of the Year award in recognition of her leadership and commitment to strengthening the bioscience industry within Rhode Island. Governor Raimondo received the award at the National Governor’s Association Summer Meeting, held at the Providence Convention Center.

BIO Applauds House Passage of Food and Drug Administration Reauthorization Act (FDARA)

Jul 12 2017
Urges swift Senate vote to ensure continuity of critical FDA functions   Washington, DC (July 12, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. House of Representatives:

BIO Statement on EPA’s Proposed 2018 Renewable Fuel Standards

Jul 5 2017
Washington, D.C. (July 5, 2017) – The Environmental Protection Agency’s proposed Renewable Fuel Standards for 2018 and biomass-based diesel volume for 2019 must be improved to support investment and capacity building for advanced and cellulosic biofuels, the Biotechnology Innovation Organization (BIO) said today. 

BIO Applauds Bipartisan Introduction of Renewable Chemicals Tax Credit

Jun 30 2017
BIO and its members thank Rep. Bill Pascrell (D-NJ) and Reps. Ryan Costello (R-PA), Brian Fitzpatrick (R-PA) and Linda Sánchez (D-CA) for introducing the Renewable Chemicals Act of 2017.

The BIO International Convention Closes after Four “Breakthrough” Days in San Diego

Jun 22 2017
The 2017 BIO International Convention  (BIO 2017), hosted by the Biotechnology Innovation Organizatio (BIO), closed today after four days of immersive, compelling programming united under the theme of “Breakthrough.”  BIO 2017 recognized past, present and future biotech breakthroughs that heal, feed and fuel the world

BIO Expands Cooperation with China-Based Pharma Group

Jun 22 2017
Memorandum of Understanding for Cooperation continues the longstanding relationship between BIO and RDPAC and deepens our cooperative efforts.